MEDI EXPRESS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDI EXPRESS
Largest movements
- Receivables within one year -€6,734
down €6,734 (-72.1%), from €9,338 to €2,605
of which Trade receivables: -€6,678
- Cash +€2,414
up €2,414 (+206.4%), from €1,170 to €3,584
mainly Receivables within one year (+€6,734) and Net result for the year (+€2,302)
- Trade debts -€3,227
down €3,227 (-28.8%), from €11,196 to €7,969
- Other debts -€3,202
down €3,202 (-77.0%), from €4,156 to €955
- Profit (loss) carried forward +€2,302
up €2,302 (+21.6%), from -€10,649 to -€8,347
- Tax, wage and social debts -€193
down €193 (-5.8%), from €3,305 to €3,112
- Write-downs -€2,059
no longer reported in 2024 (was €2,059)
- Taxes -€734
down €734 (-50.6%), from €1,451 to €716
- Other operating charges +€396
new in 2024: €396
- Gross operating margin +€294
up €294 (+7.4%), from €3,960 to €4,253
- Financial charges +€122
up €122 (+17.0%), from €717 to €839
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,508 | €6,189 | -€4,319 | -41.1% |
| Current assets | 29/58 | €10,508 | €6,189 | -€4,319 | -41.1% |
| Amounts receivable within one year | 40/41 | €9,338 | €2,605 | -€6,734 | -72.1% |
| Trade receivables | 40 | €9,283 | €2,605 | -€6,678 | -71.9% |
| Other amounts receivable | 41 | €56 | - | -€56 | |
| Cash at bank and in hand | 54/58 | €1,170 | €3,584 | +€2,414 | +206.4% |
| Total equity and liabilities | 10/49 | €10,508 | €6,189 | -€4,319 | -41.1% |
| Equity | 10/15 | -€8,149 | -€5,847 | +€2,302 | +28.3% |
| Contributions | 10/11 | €2,500 | €2,500 | = | 0.0% |
| Capital | 10 | €2,500 | - | -€2,500 | |
| Issued capital | 100 | €2,500 | - | -€2,500 | |
| Profit (loss) carried forward | 14 | -€10,649 | -€8,347 | +€2,302 | +21.6% |
| Amounts payable | 17/49 | €18,657 | €12,035 | -€6,622 | -35.5% |
| Amounts payable within one year | 42/48 | €18,657 | €12,035 | -€6,622 | -35.5% |
| Trade debts | 44 | €11,196 | €7,969 | -€3,227 | -28.8% |
| Suppliers | 440/4 | €11,196 | €7,969 | -€3,227 | -28.8% |
| Taxes, remuneration and social security | 45 | €3,305 | €3,112 | -€193 | -5.8% |
| Taxes | 450/3 | €3,305 | €3,112 | -€193 | -5.8% |
| Other amounts payable | 47/48 | €4,156 | €955 | -€3,202 | -77.0% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €2,059 | - | -€2,059 | |
| Other operating charges | 640/8 | - | €396 | +€396 | |
| Non-recurring operating charges | 66A | €1,001 | - | -€1,001 | |
| Gross operating margin | 9900 | €3,960 | €4,253 | +€294 | +7.4% |
| Operating profit (loss) | 9901 | €900 | €3,858 | +€2,958 | +328.6% |
| Financial income | 75/76B | €0 | - | -€0 | |
| Recurring financial income | 75 | €0 | - | -€0 | |
| Financial charges | 65/66B | €717 | €839 | +€122 | +17.0% |
| Recurring financial charges | 65 | €717 | €839 | +€122 | +17.0% |
| Profit (loss) for the period before taxes | 9903 | €183 | €3,018 | +€2,835 | +1548.0% |
| Income taxes | 67/77 | €1,451 | €716 | -€734 | -50.6% |
| Profit (loss) for the period | 9904 | -€1,268 | €2,302 | +€3,570 | |
| Profit (loss) for the period to be appropriated | 9905 | -€1,268 | €2,302 | +€3,570 |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.